PRESS RELEASE published on 02/25/2025 at 06:30, 1 year 5 months ago Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE® Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE®. Approval for treating retinal diseases granted by UK's MHRA Regulatory Approval UK Biosimilar Formycon AHZANTIVE
PRESS RELEASE published on 02/25/2025 at 05:26, 1 year 5 months ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3Y Change of Director's Interest Notice Dexus Finance Pty Limited announces Change of Director's Interest Notice for Rhoda Phillippo. Appendix 3Y form filed to ASX for public disclosure Real Estate Dexus Finance Pty Limited ASX Release Appendix 3Y Change Of Director's Interest Notice
PRESS RELEASE published on 02/25/2025 at 02:20, 1 year 5 months ago UniDoc - Announces Filing of Amended and Restated Interim Management Discussion and Analysis UniDoc Health Corp. issues amended and restated management's discussion and analysis for clarifying disclosure following continuous disclosure review by the British Columbia Securities Commission British Columbia Securities Commission Management's Discussion And Analysis UniDoc Health Corp. Amended Clarifying Disclosure
PRESS RELEASE published on 02/25/2025 at 00:05, 1 year 5 months ago BluSky Carbon Announces Closing of Convertible Debenture Financing and Unit Offering BluSky Carbon Inc. closes non-brokered private placement of convertible debentures and completes Unit Offering, raising funds for business development Private Placement Business Development Convertible Debentures BluSky Carbon Inc. Unit Offering
PRESS RELEASE published on 02/25/2025 at 00:00, 1 year 5 months ago Onco-Innovations' PKNP Technology Shown in Study to Demonstrate Low Toxicity and High Safety Profile Onco-Innovations Limited announces successful preclinical study results of its second-generation nanoparticle formulation of PNKP Compound, showing enhanced inhibitor delivery with minimal toxicity for potential cancer therapy Preclinical Study Cancer Therapy Onco-Innovations Limited Nanoparticle Formulation PNKP Compound
PRESS RELEASE published on 02/24/2025 at 22:15, 1 year 5 months ago Kingstone Announces Record Operating Profit and Growth for Fourth Quarter and Full Year 2024 Kingstone Companies, Inc. schedules conference call on March 14 for fourth quarter 2024 financial results. Company's preliminary financial performance highlights significant improvements in direct written premiums and operating income Financial Results Conference Call Kingstone Companies Inc. Preliminary Performance Direct Written Premiums
PRESS RELEASE published on 02/24/2025 at 21:27, 1 year 5 months ago Sanofi: Disclosure of trading in own shares
PRESS RELEASE published on 02/24/2025 at 21:15, 1 year 5 months ago Shelly achieves a successful financial year 2024 with profitable growth well above the industry average Shelly Group SE achieves successful financial year 2024 with remarkable growth exceeding industry average, driven by revenue increase and international expansion Revenue Increase Financial Year 2024 Profitable Growth International Expansion Shelly Group SE
PRESS RELEASE published on 02/24/2025 at 21:14, 1 year 5 months ago Inside Information / Other news releases Pernod Ricard successfully completes €800 million bond issuance with a coupon of 3.25% for general corporate purposes, led by Bank of America and others Bond Issuance Bank Of America PERNOD RICARD €800 Million Coupon 3.25%
PRESS RELEASE published on 02/24/2025 at 20:01, 1 year 5 months ago Press Release Related to a Proposed Public Buy-Out Offer Followed by a Squeeze-Out Concerning Tarkett’s Shares
Published on 08/06/2026 at 03:35, 1 hour 28 minutes ago Tunkillia Upgrade Drilling – 39,000m Phase 2 Complete Targeting JORC Resource Classification Upgrades; PFS Underway
Published on 08/06/2026 at 01:40, 3 hours 23 minutes ago Taranis Identifies a Hydrothermally Altered, Sulfide-Bearing Intrusive Stock Associated with Historic Gold-Silver Occurrence and Connected to Thor
Published on 08/05/2026 at 23:40, 5 hours 23 minutes ago Galantas Gold Secures Key Permitting Approvals for Andacollo Gold Project
Published on 08/05/2026 at 23:10, 5 hours 53 minutes ago Ur-Energy Announces Date for Second Quarter 2026 Results and Conference Call and Webcast
Published on 08/05/2026 at 23:01, 6 hours 2 minutes ago Full Circle Lithium Announces Extension of Current Private Placement
Published on 08/05/2026 at 23:23, 5 hours 40 minutes ago EQS-Adhoc: Enapter AG: Agreement with Patrimonium to discharge corporate bond liabilities of around EUR 26 million; realignment to an asset-light business model; capital measure planned
Published on 08/05/2026 at 23:04, 5 hours 59 minutes ago AUTODOC to publish H1 2026 report and host a conference call on Q2 results on 13 August 2026
Published on 08/05/2026 at 19:14, 9 hours 49 minutes ago 2CRSi informs the market about the governance of AETHER Infrastructures and the progress of the AETHER project in which 2CRSi takes part as a member of the consortium
Published on 08/05/2026 at 18:30, 10 hours 33 minutes ago Avolta enters Kolkata Airport, growing duty-free presence in India
Published on 08/05/2026 at 18:00, 11 hours 3 minutes ago Information concerning the total number of voting rights and shares in the share capital as of July 31, 2026
Published on 08/05/2026 at 17:49, 11 hours 13 minutes ago Mersen: Number of shares and voting rights as of July 31, 2026
Published on 08/05/2026 at 17:45, 11 hours 18 minutes ago Information concerning the total number of voting rights and shares 2026 07 31
Published on 08/05/2026 at 17:45, 11 hours 18 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 08/05/2026 at 17:42, 11 hours 21 minutes ago Aéroports de Paris SA - Shares and voting rights as of 31 July 2026